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Abstract: A moderately high-fat Mediterranean diet does not promote weight gain. This study
aimed to investigate the association between dietary intake of specific types of fat and obesity and
body weight. A prospective cohort study was performed using data of 6942 participants in the
PREDIMED trial, with yearly repeated validated food-frequency questionnaires, and anthropometric
outcomes (median follow-up: 4.8 years). The effects of replacing dietary fat subtypes for one another,
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proteins or carbohydrates were estimated using generalized estimating equations substitution models.
Replacement of 5% energy from saturated fatty acids (SFA) with monounsaturated fatty acids (MUFA)
or polyunsaturated fatty acids (PUFA) resulted in weight changes of−0.38 kg (95% Confidece Iinterval
(CI):−0.69, −0.07), and−0.51 kg (95% CI:−0.81, −0.20), respectively. Replacing proteins with MUFA
or PUFA decreased the odds of becoming obese. Estimates for the daily substitution of one portion of
red meat with white meat, oily fish or white fish showed weight changes up to −0.87 kg. Increasing
the intake of unsaturated fatty acids at the expense of SFA, proteins, and carbohydrates showed
beneficial effects on body weight and obesity. It may therefore be desirable to encourage high-quality
fat diets like the Mediterranean diet instead of restricting total fat intake.
Keywords: fat; obesity; body weight; cohort study; substitution models
1. Introduction
Obesity is one of the most important risk factors of noncommunicable diseases. The epidemic
has been described extensively in scientific literature, providing cogent evidence for its role in the
development of cardiovascular diseases, diabetes, musculoskeletal disorders, and certain types of
cancer [1]. Dietary fat intake has long been believed to be an important predictor of obesity as it is the
most energy-dense macronutrient, providing about 9 kcal per gram versus 4 kcal/g from proteins or
carbohydrates. Consequently, to control obesity, dietary guidelines have focused on reducing total fat
intake for almost four decades [2]. Even after a large body of evidence showed the beneficial health
effects of unsaturated fatty acids [3,4], total fat restrictions remained [5], as well as the gradual increase
in the global prevalence of overweight and obesity [6].
Currently, some aspects of guidelines are being revised. A report of the third FAO (Food and
Agriculture Organization of the United Nations)/WHO (World Health Organization) Expert
Consultation on Fats and Fatty Acids in Human Nutrition (Geneva, 2008) showed the focus is clearly
shifting from fat quantity to quality [7]. Additionally, the latest US Dietary Guidelines Advisory
Committee (DGAC) report concluded that emphasis should be put on optimizing types of dietary
fat and not reducing total fat [5]. The quality of fat is generally specified by the relative intake
of monounsaturated (MUFA) and polyunsaturated fatty acids (PUFA) versus saturated (SFA) and
trans fatty acids. Furthermore, PUFA may be subdivided into plant-derived linoleic (C18:2n-6)
and α-linolenic acid (ALA, C18:3n-3) and marine-derived eicosapentaenoic (EPA, 20:5n-3) and
docosahexaenoic acid (DHA, C22:6n-3) [8].
The Mediterranean diet (MeDiet) is typically high in fat and there is evidence about its role in the
prevention of cardiovascular disease [9,10], in which the proportions of unsaturated and saturated
fatty acids have been shown to play an important role [11]. Moreover, multiple systematic reviews and
meta-analyses have shown a MeDiet does not promote weight gain [12–15]. In fact, it may even result
in greater and more long-lasting weight loss than low-fat diets and be protective against increases
in waist circumference [12–15]. This outcome has also been shown for nut intake, a predominant
food product in the MeDiet [16–18]. Other food, more specific components of the MeDiet, and their
association with obesity-related outcomes have not received as much attention to date.
Although assessing a complete dietary pattern provides insight into the cumulative effects of
consuming certain products, determining which nutrients or food items induce the greatest change
may lead to better understanding of the associations. The main objective of this study is therefore to
investigate the association between dietary fat intake of both specific types of fatty acids and of food
items within the MeDiet and body weight and obesity.
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2. Materials and Methods
2.1. Study Population
This prospective study was a secondary analysis using data of the large, randomized
controlled trial PREDIMED (prevención con dieta Mediterránea, prevention with Mediterranean
diet). Participants within the PREDIMED study were Spanish men and women at high risk for
cardiovascular disease, recruited from multiple centers across the country between October 2003 and
June 2009. After inclusion, participants were assigned to two groups receiving a MeDiet supplemented
with either extra virgin olive oil or mixed nuts, and—in the case of the control group—solely receiving
advice on following a low-fat diet. The PREDIMED protocol was approved by institutional review
boards and all participants provided written informed consent. Further details on the design and
protocol of the study have been described elsewhere [19,20].
The trial was stopped in December 2010 and included 7447 participants. After exclusion of
participants without food-frequency questionnaire (FFQ) data, without BMI follow-up data, with
implausible energy intakes (<800 or >4200 kcal/day in men <500 and >3500 kcal/day in women) [21]
or without other data necessary to perform the analyses, the population available for the present
analyses included 6942 participants with a median follow-up of 4.8 years (interquartile range: 2.9
to 5.8).
2.2. Dietary Exposure Assessment
At baseline and yearly thereafter, a semiquantitative 137-item food-frequency questionnaire (FFQ)
was collected and reviewed by trained, registered dieticians. The used FFQ was repeatedly validated
and found to be highly reproducible and have a reasonably good validity with regard to nutrient intake
reported [22,23]. Spanish food-composition tables were used to derive energy and nutrient intake [24].
Dietary intakes were considered as the cumulative average of all available data, from baseline to each
follow-up measurement, to optimally represent long-term intake and reduce measurement error [25].
2.3. Outcome Assessment
Anthropometric measurements were taken by trained personnel once a year. Weight was
measured on a calibrated scale, without shoes and with light clothing. Height was determined
using a wall-mounted stadiometer.
Participants with a BMI ≥25 and <30 kg/m2 were classified as overweight and ≥30 kg/m2 as
obese. Substantial weight gain or loss was defined as a change ≥10% when compared to baseline
body weight [26]. Body weight was analyzed as continuous outcomes and dichotomized using this
cut-off (a change ≥10%), additional to the dichotomous variables for incidence (increasing to a BMI
≥30 kg/m2) and reversion of obesity (decreasing to a BMI <30 kg/m2).
2.4. Assessment of Other Variables
At each yearly visit, sociodemographic variables and risk factors like educational level and
working, marital, and smoking status were assessed using in a general questionnaire. Physical activity
was assessed using the Spanish version of Minnesota Leisure-Time Physical Activity, validated in both
sexes [27,28]. Based on frequency and duration of 67 activities, a MET (Metabolic equivalents) score was
assigned to each participant. The analyses considered updated the measurements of these covariates
and in case of missing data, the last observations were carried forward to prevent participants being
excluded from the analyses.
2.5. Statistical Analyses
Participant characteristics were reported according to extreme quintiles of fatty acid intakes, as
mean (SD) for continuous variables and % for categorical variables.
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Generalized estimating equations (GEE) were fit to analyze the association between the cumulative
average of yearly measured consumption of dietary fatty acids and body weight. For these continuous
outcomes, the distribution was set to Gaussian and link function to identity. Effects of isocaloric
substitution of fat types for one another, carbohydrates, and proteins were estimated as the difference
between β coefficients of macronutrients exchanged per 5% of energy from these sources. Logistic
GEE regression models were used to determine odds ratios for incidence and reversion of obesity
and ≥10% changes in body weight. The effects of replacing specific high-fat food products for other,
higher-quality options were estimated using non-isocaloric substitution models, by considering the
replacement of single portions of meat, fish and seafood (100 g), oils, butter and margarine (10 g), and
nuts (30 g). For all GEE models, an exchangeable correlation structure was assumed.
The model included intakes of all energy delivering dietary variables except for one (the last one
being omitted as they add up to 100% for any person) and was adjusted for age, sex, intervention
group, baseline BMI or body weight, leisure-time physical activity (quintiles of MET-min/week),
smoking status (never, former, current smoker), educational level (none/primary, secondary,
academic/graduate), working status (employed, unemployed, housewife, retired), marital status
(single/widowed, married), and dietary fiber intake (continuous).
Sensitivity analyses were performed using mixed-effects models instead of GEE models and both
observed and updated measurements of exposure instead of cumulative averages. Missing values of
dietary variables and weight were imputed using multilevel multiple imputation in the GEE model
with body weight as the continuous outcome. Data were assumed to be MAR (missing at random) and
m = 20 datasets were created using multivariate normal (MVN) as the imputation algorithm [29].
All statistical analyses were performed using STATA/SE V.12.1 (StataCorp, College Station, TX,
USA) and p-values < 0.05 were considered statistically significant.
3. Results
3.1. Baseline Characteristics
The population available for the analyses consisted of 6942 participants with a mean age of 67
(SD: 6) years and of which a proportion of 47% was obese at baseline. Table 1 shows the baseline
characteristics of participants. Mean total fat intake was 30.5% of total energy intake (EN%) in the
lowest quintile versus 50.6 EN% in the highest.
3.2. Substitution of Fat Subtypes
3.2.1. Body Weight Differences
The results of GEE substitution models presented in Table 2 show the predicted effects of replacing
5% of energy from a specific fat subtype for 5 EN% of another fat subtype, proteins or carbohydrates.
The results suggested consuming PUFA is associated with a significant weight difference when
replacing SFA (mean change −0.51 kg; 95% confidence interval (CI): −0.81, −0.20), proteins (−0.27 kg;
95% CI: −0.49, −0.04) or carbohydrates (−0.20 kg; 95% CI: −0.37, −0.02). Additionally, isocaloric
substitution of 5 EN% of SFA with MUFA was inversely associated with body weight (−0.38, 95% CI:
−0.69, −0.07). Increasing SFA at the expense of carbohydrates was found to be directly associated
with body weight (0.31 kg; 95% CI: 0.06, 0.56).
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Table 1. Participant characteristics according to extreme quintiles of total fat (in EN%) at baseline 1.
Q1 Q5
Participants, n 1391 1387
Age (year) 67 (6) 67 (6)
Women (%) 53.9 62.5
Control group (%) 35.6 32.2
Physical activity (MET-min/week) 249 (259) 216 (226)
Smoking habit: Never smoker (%) 61.0 64.4
Smoking habit: Former smoker (%) 24.4 22.4
Smoking habit: Current smoker (%) 14.6 13.2
Marital status: Married (%) 75.0 76.5
Marital status: Single/widowed (%) 25.0 23.5
Educational level: Lower than high school (%) 80.5 75.3
Educational level: High school (%) 11.9 17.7
Educational level: University (%) 7.6 7.0
Employment status: Employed/housewife 41.6 51.8
Employment status: Unemployed (%) 3.5 3.5
Employment status: Retired (%) 54.9 44.7
Total energy intake (kcal/day) 2262 (573) 2163 (513)
Carbohydrates (EN%) 51.6 (5.8) 35.1 (4.5)
Protein (EN%) 17.4 (3.1) 16.7 (2.8)
Total fat (EN%) 27.7 (3.2) 46.5 (3.7)
MUFAs (EN%) 14.4 (2.4) 26.3 (3.4)
PUFAs (EN%) 5.0 (1.6) 7.9 (2.4)
SFAs (EN%) 8.1 (1.7) 12.1 (2.1)
trans fat (EN%) 0.18 (0.12) 0.28 (0.17)
Alcohol (g/day) 11.2 (18.7) 5.1 (9.2)
Dietary fiber (g/day) 28.9 (10.1) 21.7 (6.6)
1 Q, quintile; MET, metabolic equivalent task; EN%, energy as a proportion of total energy intake. Data are mean
(SD) unless otherwise stated.
Table 2. Estimated mean changes (95% confidence interval) 1 in body weight (kg) after isocaloric
substitutions of 5% energy from MUFA, PUFA, and SFA, proteins, and carbohydrates.
Substitution ↑MUFA ↑PUFA ↑SFA
↓PUFA 0.13 (−0.09, 0.34) - -
↓SFA −0.38 (−0.69, −0.07) * −0.51 (−0.81, −0.20) * -
↓proteins −0.14 (−0.30, 0.02) −0.27 (−0.49, −0.04) * 0.24 (−0.08, 0.56)
↓carbohydrates −0.07 (−0.17, 0.03) −0.20 (−0.37, −0.02) * 0.31 (0.06, 0.56) *
1 Adjusted for age, sex, baseline weight, recruitment center, intervention group, cumulative average of total
energy intake, BMI, leisure-time physical activity (metabolic equivalent task in min/day), smoking status
(never, former, current smoker), educational level (primary education, high school, university), working status
(employed, unemployed, housewife, retired), and marital status (single, married). * p < 0.05. ↑ means increases,
↓means decreases.
3.2.2. Obesity Incidence and Reversion, Substantial Weight Gain and Loss
In a total number of 3700 initially non-obese participants, 657 incident cases of obesity were
observed during follow-up. Table 3 shows the results of the logistic GEE investigating the association
between nutrient substitution and 2 dichotomous outcomes: Obesity incidence and substantial weight
gain (≥10%).
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Table 3. Estimated odds ratios (95% confidence interval) 1 for incidence of obesity and substantial
weight gain (≥10%) after isocaloric substitution of 5% energy from MUFA, PUFA, and SFA, proteins,
and carbohydrates.
Substitution Obesity Incidence Weight Gain (≥10%)
↑MUFA, ↓PUFA 1.36 (1.02, 1.81) * 1.16 (0.82, 1.65)
↑MUFA, ↓SFA 1.04 (0.69, 1.56) 1.11 (0.71, 1.65)
↑MUFA, ↓Proteins 0.85 (0.69, 1.03) 0.82 (0.66, 1.02)
↑MUFA, ↓Carbohydrates 1.08 (0.95, 1.23) 1.02 (0.87, 1.18)
↑PUFA, ↓SFA 0.77 (0.51, 1.15) 0.96 (0.62, 1.47)
↑PUFA, ↓Proteins 0.62 (0.47, 0.83) * 0.70 (0.50, 0.99) *
↑PUFA, ↓Carbohydrates 0.80 (0.63, 1.01) 0.87 (0.67, 1.15)
↑SFA, ↓Proteins 0.81 (0.53, 1.24) 0.73 (0.46, 1.17)
↑SFA, ↓Carbohydrates 1.04 (0.75, 1.24) 0.91 (0.63, 1.31)
1 Adjusted for age, sex, baseline weight, recruitment center, intervention group, cumulative average of total
energy intake, BMI, leisure-time physical activity (metabolic equivalent task in min/day), smoking status (never,
former, current smoker), educational level (primary education, high school, university), working status (employed,
unemployed, housewife, retired), and marital status (single, married). * p < 0.05.
Replacing 5 EN% of proteins with 5 EN% of PUFA decreased the odds of obesity incidence (OR:
0.62, 95% CI: 0.47, 0.83) and ≥10% weight gain (OR: 0.70, 95% CI: 0.50, 0.99). The odds ratio (95% CI)
for obesity incidence was 1.36 (1.02, 1.81) when 5 EN% of PUFA was replaced by MUFA. Reversion
of obesity occurred 819 times within the 3242 participants who were obese at baseline. Note that in
Figure 1 an odds ratio (OR) >1 indicates increased odds of reversion of obesity or weight loss (≥10%),
so desirable changes.
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Figure 1. Estimated odds ratios (95% confidence interval) for reversion of obesity (grey squares) and
substantial weight loss (≥10%, black diamonds) after isocaloric substitution of 5% energy from MUFA,
PUFA, and SFA, proteins (Prot), and carbohydrates (CHO). Adjusted for the same confounders as the
analyses in Table 3.
Replacing SFA with PUFA significantly increased the odds of the reversion of obesity (OR: 1.57,
95% CI: 1.09, 2.25) and substantial weight loss (OR: 1.58, 95% CI: 1.09, 2.28). Slightly less strong but
significant associations were found for the odds of substantial weight loss when PUFA intake was
increased at the expense of proteins (OR: 1.44, 95% CI: 1.12, 1.86) or carbohydrates (OR: 1.29, 95%
CI: 1.06, 1.57). Increasing MUFA at the expense of PUFA resulted in an OR of 0.78 (0.61, 1.00) for a
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≥10% weight loss. As a summary, all significant results in Table 3 and Figure 1 advocate for a higher
PUFA intake.
3.3. Substitution of Food Items
The estimated effects of non-isocaloric food item substitutions on body weight are shown in
Table 4. Significant weight difference estimates were observed when daily replacing a 100 g portion of
red meat with white meat (−0.64 kg, 95% CI: −0.94, −0.35), oily fish (−0.75 kg, 95% CI: −1.13, −0.38)
or white fish (−0.87 kg, 95% CI −1.17, −0.56).
Table 4. Estimated mean changes in body weight (kg) (95% confidence interval) 1 after substitution of
one daily portion of high-fat food items in the MeDiet for a priori healthier options.
Substitution Mean Body Weight (kg) Difference (95% Confidence Interval)
↓Red meat, ↑White meat −0.64 (−0.94, −0.35) *
↓Red meat, ↑Oily fish −0.75 (−1.13, −0.38) *
↓Red meat, ↑White fish −0.87 (−1.17, −0.56) *
↓Butter, ↑Olive oil −0.25 (−0.56, 0.06)
↓Butter, ↑Other vegetable oils −0.11 (−0.44, 0.22)
↓Margarine, ↑Olive oil 0.04 (−0.18, 0.25)
↓Margarine, ↑Other vegetable oils 0.26 (0.02, 0.50) *
↓Mixed nuts, ↑Walnuts −0.15 (−0.61, 0.32)
1 Substitutions of a portion of 100, 10 and 30 g for meat/fish, butter/margarine/oils, and nuts, respectively. Adjusted
for age, sex, baseline weight, recruitment center, intervention group, cumulative average of total energy intake,
BMI, leisure-time physical activity (metabolic equivalent task in min/day), smoking status (never, former, current
smoker), educational level (primary education, high school, university), working status (employed, unemployed,
housewife, retired), and marital status (single, married). * p < 0.05. ↑means increases, ↓means decreases.
Replacing a 10 g portion of margarine with vegetable oils other than olive oil resulted in a
significant estimate, suggesting a weight gain of 0.26 kg (95% CI: 0.02, 0.50). No significant associations
were observed for the replacement of butter and margarine with olive oil or replacing 30 g of mixed
nuts with an equivalent portion of walnuts.
Estimates of nutrient substitutions for continuous outcomes were consistent when using
mixed-effects models with random intercepts for recruitment center and identity level. Mixed-effects
models are a little more conservative, however, thus showing wider confidence intervals (data not
shown).
4. Discussion
The results of this prospective study suggest that increasing the intake of unsaturated fatty acids
(especially PUFA) at the expense of SFA, proteins, and carbohydrates may have beneficial effects on
body weight and obesity. Reversing obesity seems to be especially successful when replacing SFA with
PUFA, and replacing proteins with PUFA lowers the risk of becoming obese in the first place. Increasing
MUFA at the expense of PUFA, on the other hand, shows a significantly increased risk of becoming
obese. These findings are in line with previous research [30], although there is still controversy [31].
Most prior research on the association between dietary fat and overweight/obesity merely considered
total fat intake or the MeDiet as a whole. Evidence from 53 randomized controlled trials summarized in
a systematic review and meta-analysis did not support low-fat diets over other dietary interventions for
long-term weight loss, when compared with dietary interventions of similar intensity [15]. A systematic
review of 5 RCTs found the MeDiet resulted in greater weight loss than low-fat diet at ≥12 months but
produced results similar to other comparator diets, like a low-carbohydrate diet [14]. These results are
in line with an earlier meta-analysis [13]. Although the results of the included studies were inconsistent
and the meta-analyses reported significant heterogeneity, the evidence ultimately points towards a
role of a high-quality, moderately high-fat diet like the MeDiet in the prevention of overweight and
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obesity. Results of the PREDIMED trial supported that the intervention did not have a differential
effect on body weight compared to the control group [32].
One prospective study in a Spanish sample of the EPIC (European Prospective Investigation into
Cancer and Nutrition) study further focused on dietary fat subtypes and concluded that the association
between consumption of specific types of dietary fat, olive oil, and obesity in Spain was not very
important [33]. However, the design of the study was cross-sectional. Ten years later, the results of the
EPIC–PANACEA study showed the MeDiet may prevent weight gain and the development of obesity.
Unfortunately, this study did not distinguish between types of fat [34].
Previous PREDIMED studies showed a protective effect of MeDiet interventions supplemented
by olive oil or nuts and of dairy consumption [35,36]. Moreover, extensive evidence was found that
nut consumption does not increase body weight and obesity incidence and may even be inversely
associated with these outcomes [17,37,38]. Most nuts are especially high in MUFA, whereas walnuts
are rich in PUFA. Adherence to the MeDiet in general has also been shown to be directly associated
with fulfilling nutrient recommendations [39,40].
Another important finding of our study, in the context of substitution models, is that reductions
in red meat consumption coupled with respective increases in white meat or fish would lead to less
weight gain. This is important because it represents a translation of fat substitution models into food
item replacement models and it generates a comprehensible and easily understandable message for
the population. This is in accordance with the concept of the MeDiet, which fosters the preference for
white meat consumption over red meat and includes regular fish consumption. It is also important to
focus on specific food groups or items, since different foods rich in a specific fat subtype may have
different effects on body weight [41].
The satiating effect of the MeDiet may explain some beneficial effects on body weight, especially
in a longer term. Furthermore, evidence shows mono- and polyunsaturated fatty acids are more readily
oxidized than saturated fatty acids and have a greater thermogenic effect, which can lead to reduced fat
accumulation [42]. The quantity and quality of dietary fat have also been shown to induce differential
lipid storage and processing gene expression, influencing adipokines release, but this process and
regulation is still only partially understood [43]. Adherence to MeDiet may also be inversely correlated
with proinflammatory biomarkers [44], and another potential important mechanism is the influence
on adipose tissue metabolism and secretory functions [45].
The major strengths of the present research include its prospective design, large sample size,
and repeated measurements of exposure, outcomes, and confounders over a long follow-up period.
Due to comprehensive data records, most relevant confounders could be controlled for. Nevertheless,
residual confounding is possible. Genetic determinants for instance may influence measures of
obesity and were not available in the dataset [46]. Systematic error may be present due to the large
proportion of obese individuals, known to have a tendency to underestimate their dietary intakes
(in particular total energy intake) and overestimate physical activity; however, this error will probably
be nondifferential [47]. Furthermore, well-known measurement errors as a result of methodological
issues in the memory-based assessment of dietary factors and physical activity may bias the results.
The study of waist circumference as a potential outcome measure was also considered and would
shine light on the matter, but the risk of substantial measurement error, especially in overweight
and obese participants [48], makes it worthy of special attention and more complex analyses are
warranted, so we decided not to include it in this manuscript for the sake of simplicity. Both the
FFQ and physical activity questionnaire have been validated, however [22,23,27,28]. Energy-adjusted
intraclass correlation coefficients for MUFAs, PUFAs, and SFAs in four 3-day dietary records and the
FFQ were 0.61, 0.60, and 0.75, respectively [22]. Analyses of trans fatty acids were considered. Intake
of this fat subtype was very low in this study, however (0.47 ± 0.13 EN%); thus, these investigations
may be more effective in a different population.
This study cannot fully demonstrate causality of the observed associations. Obesity and body
weight may be susceptible to reverse causation in the sense that once their body changes, participants
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adjust their eating habits [49]. The use of a generalized estimating equation was chosen for all of the
analyses. An alternative could have been multilevel mixed-effects models. Both GEE and mixed-effect
methods are appropriate for longitudinal data as they account for within-subject correlations occurring
as a result of repeated measurements, but GEE models are more flexible. For linear regression models
with continuous outcomes, the random effects assumption is equivalent to an exchangeable correlation
structure in GEE [50]. The sensitivity analyses confirmed this as estimates were very similar, though the
outcomes of the mixed-effects models were more conservative with wider confidence intervals. Models
assessing the effect of actual changes in diet on changes in weight may lead to more interpretable
results and better conclusions [41].
Although a lot of effort was put into collecting complete data, missing data are unavoidable in
longitudinal studies. Throughout the years, this problem has been well documented and a range
of solutions have been proposed [29]. In this case, multiple imputation was used only for the GEE
model with body weight as a continuous outcome, to verify that the results obtained by complete
case analyses with covariate adjustment were indeed unbiased. Multiple imputation is flexible when
it comes to assumptions regarding the randomness of the missing data, which makes it suitable for
sensitivity analyses in the case of MNAR scenarios. Complete case analysis was used for further
analyses as the results were similar and this method is less time-consuming, more transparent, and at
least as efficient as multiple imputation [29].
The population of this study consisted of older participants at high risk of cardiovascular disease
and (almost all) overweight or obese at baseline, which may affect the generalizability of the findings.
The number of subjects was, however, very large, and subjects came from different social levels
and geographical areas and biological mechanisms will be similar in other populations. Moreover,
mean total fat intake represented 40.5% of the total energy intake in this study population, which is
comparable to the intake observed in a pooled analysis of studies across Spain [51]. Mean intakes of
fat subtypes were slightly more desirable than intakes measured previously in Spain: MUFA 20.2 in
the present study versus 15.9 EN%, PUFA 6.5 versus 5.6 EN% and SFA 10.3 versus 12.0 EN%.
Lastly, body weight was a secondary outcome in the PREDIMED trial. Neither energy restriction
nor increased physical activity were advised for any treatment arm, as the intervention was not
designed with the intention of causing weight loss. It should also be noted that one diet does not fit
all, and weight control strategies should be based on personal goals. The MeDiet could, however,
be a useful method to achieve personal goals, due to its high palatability and satiating effects and,
therefore, better adherence [46]. Integrating energy restriction and increased physical activity could
further enhance weight loss and health benefits [38]. Currently, data are being collected for the
PREDIMED-Plus trial, including an intensive lifestyle intervention program with an energy-restricted
MeDiet, increased physical activity, and behavioral treatment.
5. Conclusions
In conclusion, this study provides evidence that increasing MUFA and PUFA intakes at the
expense of SFA, proteins, and carbohydrate intakes may contribute to losing weight and reverse
the state of obesity in an older and overweight/obese Spanish population. It could therefore be
recommendable to encourage a high-quality, moderately high-fat eating pattern like the MeDiet, which
means increasing the quality of dietary fat instead of restricting total fat intake in the prevention
of obesity.
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